Arterial hypertension associated with hyperuricemia: features of heart damage

Olha M Chernatska1, Liudmyla N Prystupa1, Hanna A Fadieieva1

  • 1Internal Medicine Department, Medical Institute, Sumy State University, Sumy, Ukraine.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|May 10, 2020
PubMed

Insights

Hyperuricemia significantly increases left ventricular mass index in patients with arterial hypertension, indicating its role in developing left ventricular hypertrophy. This finding highlights the importance of managing uric acid levels in hypertensive individuals.

Area of Science:

  • Cardiology
  • Nephrology
  • Metabolic Disorders

Background:

  • Arterial hypertension is a major risk factor for cardiovascular diseases.
  • Hyperuricemia, elevated uric acid levels, is increasingly recognized as a potential contributor to cardiovascular complications.
  • The relationship between hyperuricemia and cardiac remodeling in hypertensive patients requires further elucidation.

Purpose of the Study:

  • To analyze the influence of hyperuricemia on cardiac features in patients with arterial hypertension.
  • To investigate the association between serum uric acid levels and left ventricular hypertrophy (LVH).

Main Methods:

  • A study involving 75 patients with arterial hypertension, divided into groups based on uric acid levels.
  • Inclusion of 30 healthy individuals as a control group.
  • Assessment of left ventricular mass index (LVMI) to confirm left ventricular hypertrophy, utilizing clinical, anthropometric, biochemical, and instrumental methods.

Main Results:

  • Patients with arterial hypertension and hyperuricemia exhibited a significantly higher left ventricular mass index (109.7 ± 3.21 g/m²) compared to those with arterial hypertension alone (97.6 ± 5.35 g/m²).
  • Left ventricular mass index showed a positive correlation with serum uric acid levels (r = 0.31; p = 0.04) in patients with arterial hypertension and hyperuricemia.
  • The findings suggest a proportional increase in LVH with rising uric acid levels.

Conclusions:

  • Hyperuricemia plays a significant role in the development of left ventricular hypertrophy in patients with arterial hypertension.
  • Elevated left ventricular mass index, correlated with uric acid levels, confirms the impact of hyperuricemia on cardiac structure.
  • Management of hyperuricemia may be crucial in preventing or mitigating cardiac remodeling in hypertensive individuals.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
364
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
221
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
253
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
613
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
779